CXCR5 and non-Hodgkin lymphoma: In addition, we assessed the cytolytic capacity of CXCR5 CAR-T cells against the DOHH-2, OCI-Ly7, SU-DHL-4, SC-1, and JeKo-1 B-NHL cell lines and against a B-ALL and a MM cell line (NALM-6 and NCI-H929, respectively).